Showing results (171-180 of 206) with videos related to
Sort By:
Pageof 21
Immunity|May 18, 2017
Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding LoopEvan M Cale, Jason Gorman, Nathan A Radakovich, et al.Cell Reports|February 15, 2018
Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing AntibodyYoung D Kwon, Gwo-Yu Chuang, Baoshan Zhang, et al.Cell Reports. Medicine|May 31, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functionsAndrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.Biorxiv : the Preprint Server for Biology|January 31, 2024
Discovery and Characterization of a Pan-betacoronavirus S2-binding antibodyNicole V Johnson, Steven C Wall, Kevin J Kramer, et al.Biorxiv : the Preprint Server for Biology|February 3, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.Cell Reports|December 28, 2017
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal ModelsKevin O Saunders, Laurent K Verkoczy, Chuancang Jiang, et al.Plos Pathogens|March 2, 2021
Correction: RV144 HIV-1 vaccination impacts post-infection antibody responsesThembi Mdluli, Ningbo Jian, Bonnie Slike, et al.Structure (London, England : 1993)|September 26, 2024
Discovery and characterization of a pan-betacoronavirus S2-binding antibodyNicole V Johnson, Steven C Wall, Kevin J Kramer, et al.Immunity|August 6, 2013
Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodiesTongqing Zhou, Jiang Zhu, Xueling Wu, et al.Plos Pathogens|December 8, 2020
RV144 HIV-1 vaccination impacts post-infection antibody responsesThembi Mdluli, Ningbo Jian, Bonnie Slike, et al.Pageof 21